These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 8248842)

  • 1. [Dosage specification at the ICRU reference point: the consequences for clinical practice. International Commission on Radiation Units and Measurements].
    Hess CF; Christ G; Jany R; Bamberg M
    Strahlenther Onkol; 1993 Nov; 169(11):660-7. PubMed ID: 8248842
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ICRU reference dose in an era of intensity-modulated radiation therapy clinical trials: correlation with planning target volume mean dose and suitability for intensity-modulated radiation therapy dose prescription.
    Yaparpalvi R; Hong L; Mah D; Shen J; Mutyala S; Spierer M; Garg M; Guha C; Kalnicki S
    Radiother Oncol; 2008 Dec; 89(3):347-52. PubMed ID: 18762345
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dose and volume parameters for MRI-based treatment planning in intracavitary brachytherapy for cervical cancer.
    Kirisits C; Pötter R; Lang S; Dimopoulos J; Wachter-Gerstner N; Georg D
    Int J Radiat Oncol Biol Phys; 2005 Jul; 62(3):901-11. PubMed ID: 15936576
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Simultaneous beam geometry and intensity map optimization in intensity-modulated radiation therapy.
    Lee EK; Fox T; Crocker I
    Int J Radiat Oncol Biol Phys; 2006 Jan; 64(1):301-20. PubMed ID: 16289912
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Importance of protocol target definition on the ability to spare normal tissue: an IMRT and 3D-CRT planning comparison for intraorbital tumors.
    Hein PA; Gladstone DJ; Bellerive MR; Hug EB
    Int J Radiat Oncol Biol Phys; 2005 Aug; 62(5):1540-8. PubMed ID: 16029816
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regarding: Rosenthal DI, Glatstein E. "We've Got a Treatment, but What's the Disease?" The Oncologist 1996;1.
    Lunsford LD; Flickinger JC; Larson D
    Oncologist; 1997; 2(1):59-61. PubMed ID: 10388030
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intensity-modulated radiation therapy dose prescription, recording, and delivery: patterns of variability among institutions and treatment planning systems.
    Das IJ; Cheng CW; Chopra KL; Mitra RK; Srivastava SP; Glatstein E
    J Natl Cancer Inst; 2008 Mar; 100(5):300-7. PubMed ID: 18314476
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Point vs. volumetric bladder and rectal doses in combined intracavitary-interstitial high-dose-rate brachytherapy: correlation and comparison with published Vienna applicator data.
    Yaparpalvi R; Mutyala S; Gorla GR; Butler J; Mah D; Garg MK; Kalnicki S
    Brachytherapy; 2008; 7(4):336-42. PubMed ID: 18782683
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluating the influence of setup uncertainties on treatment planning for focal liver tumors.
    Balter JM; Brock KK; Lam KL; Tatro D; Dawson LA; McShan DL; Ten Haken RK
    Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):610-4. PubMed ID: 16095848
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Initial experience using intensity-modulated radiotherapy for recurrent nasopharyngeal carcinoma.
    Lu TX; Mai WY; Teh BS; Zhao C; Han F; Huang Y; Deng XW; Lu LX; Huang SM; Zeng ZF; Lin CG; Lu HH; Chiu JK; Carpenter LS; Grant WH; Woo SY; Cui NJ; Butler EB
    Int J Radiat Oncol Biol Phys; 2004 Mar; 58(3):682-7. PubMed ID: 14967420
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Isoeffective dose: a concept for biological weighting of absorbed dose in proton and heavier-ion therapies.
    Wambersie A; Menzel HG; Andreo P; DeLuca PM; Gahbauer R; Hendry JH; Jones DT
    Radiat Prot Dosimetry; 2011 Feb; 143(2-4):481-6. PubMed ID: 21138926
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment plan comparison between helical tomotherapy and MLC-based IMRT using radiobiological measures.
    Mavroidis P; Ferreira BC; Shi C; Lind BK; Papanikolaou N
    Phys Med Biol; 2007 Jul; 52(13):3817-36. PubMed ID: 17664579
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of linac based fractionated stereotactic radiotherapy and tomotherapy treatment plans for skull-base tumors.
    Soisson ET; Tomé WA; Richards GM; Mehta MP
    Radiother Oncol; 2006 Mar; 78(3):313-21. PubMed ID: 16490269
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The RBE issues in ion-beam therapy: conclusions of a joint IAEA/ICRU working group regarding quantities and units.
    Wambersie A; Hendry JH; Andreo P; DeLuca PM; Gahbauer R; Menzel H; Whitmore G
    Radiat Prot Dosimetry; 2006; 122(1-4):463-70. PubMed ID: 17229786
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A phase I/II trial to evaluate three-dimensional conformal radiation therapy confined to the region of the lumpectomy cavity for Stage I/II breast carcinoma: initial report of feasibility and reproducibility of Radiation Therapy Oncology Group (RTOG) Study 0319.
    Vicini F; Winter K; Straube W; Wong J; Pass H; Rabinovitch R; Chafe S; Arthur D; Petersen I; McCormick B
    Int J Radiat Oncol Biol Phys; 2005 Dec; 63(5):1531-7. PubMed ID: 16198508
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The implementation of an advanced treatment planning algorithm in the treatment of lung cancer with conventional radiotherapy.
    Pearson M; Atherton P; McMenemin R; McDonald F; Mazdai G; Mulvenna P; Lambert G
    Clin Oncol (R Coll Radiol); 2009 Apr; 21(3):168-74. PubMed ID: 19162457
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quality assurance in brachytherapy: the role of the ICRU in achieving uniformity in dose and volume specification for reporting.
    Wambersie A; Chassagne D; Dutreix A; Almond P; Ash D; Burgers M; Bush M; Cohen M; Hanson W; Joslin C; Landberg T; Visser A; Wilson F
    Rays; 1996; 21(4):541-58. PubMed ID: 9122439
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical implementation of intensity-modulated arc therapy (IMAT) for rectal cancer.
    Duthoy W; De Gersem W; Vergote K; Boterberg T; Derie C; Smeets P; De Wagter C; De Neve W
    Int J Radiat Oncol Biol Phys; 2004 Nov; 60(3):794-806. PubMed ID: 15465196
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is intensity-modulated radiotherapy better than conventional radiation treatment and three-dimensional conformal radiotherapy for mediastinal masses in patients with Hodgkin's disease, and is there a role for beam orientation optimization and dose constraints assigned to virtual volumes?
    Girinsky T; Pichenot C; Beaudre A; Ghalibafian M; Lefkopoulos D
    Int J Radiat Oncol Biol Phys; 2006 Jan; 64(1):218-26. PubMed ID: 16169675
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative study of reference points by dosimetric analyses for late complications after uniform external radiotherapy and high-dose-rate brachytherapy for cervical cancer.
    Chen SW; Liang JA; Yeh LS; Yang SN; Shiau AC; Lin FJ
    Int J Radiat Oncol Biol Phys; 2004 Oct; 60(2):663-71. PubMed ID: 15380604
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.